Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study.
Early relapses, onset of progression, and late outcome in multiple sclerosis.
Cross-cultural Adaptation, Reliability, and Validity of the BICAMS in Brazil.
Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
The effect of Nintendo(R) Wii(R) on balance in people with multiple sclerosis: a pilot randomized control study.
The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.
Pregnancy outcomes in female patients and partners of male patients in the teriflunomide clinical development program.
ALAIN01-Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential.
3D models of human ERα and ERβ complexed with coumestrol.
Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
Depakote: No Prescription Cheap Low
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
Therapeutic Testosterone Administration Preserves Excitatory Synaptic Transmission in the Hippocampus during Autoimmune Demyelinating Disease.
Accentia Biopharmaceuticals Conducts Investigator Meeting in Preparation for New Multiple Sclerosis Drug Study for Cyrevia™
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects.
Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice.
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
22nd Meeting of European Neurological Society
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
Generic Midamor

Pages